Image
Sale
Research Blend

KLOW Blend

4.9 (121 Reviews)
View Certificate of Analysis

A four-peptide research blend combining KPV, GHK-Cu, TB-500, and BPC-157. KLOW targets inflammatory, regenerative, and skin pathways through complementary mechanisms.

BUNDLE & SAVE
We accept
For RESEARCH USE ONLY (RUO).
About the Peptide

Four peptides for the inflammation conversation.

KLOW is a research blend that brings together four peptides whose mechanisms overlap in inflammation, healing, and skin biology: KPV for its anti-inflammatory profile, GHK-Cu for collagen and dermal support, TB-500 for systemic recovery, and BPC-157 for tissue repair.

Inflammation is rarely just one thing. For women, it shows up as skin reactivity, joint discomfort, gut sensitivity, and the cumulative wear that doesn’t resolve as quickly as it used to. KLOW was formulated for researchers studying how multiple anti-inflammatory and reparative pathways interact when engaged together.

Each component has its own published research base. Together, they cover four distinct pathways in the inflammatory and regenerative literature — the kind of broad-spectrum approach researchers use when single-pathway interventions miss the bigger picture.

Research Applications

When inflammation is more than one thing.

Most anti-inflammatory research targets a single pathway. KLOW pairs four peptides whose mechanisms overlap exactly where chronic inflammation actually lives.

Inflammatory Modulation


KPV anchors the blend with its well-studied profile in dampening inflammatory signaling at the cellular level, particularly in skin and gut research.

Skin & Tissue Support


GHK-Cu and BPC-157 contribute complementary mechanisms in collagen synthesis and soft tissue repair — the structural side of the inflammation conversation.

Systemic Recovery


TB-500 rounds out the blend with its broader role in cellular migration, vascular formation, and the body’s systemic recovery response.
How to read a peptide Vial
Certificate of Analysis

Independently Tested. Verified by Batch.

Current Batch  • KLO80MGA
99.70%
Purity
Tested Purity by HPLC
80mg
Content

Labeled amount per vial

90.65mg
Net Content
Actual amount per vial
GHK-Cu/KPV/Thymosin Beta-4/BPC-157
Identification
Mass spectrometry confirmed
View COA
Frequently Asked

Questions.